{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:02:44Z","timestamp":1793329364702,"version":"4.5.0"},"reference-count":71,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,11,27]]},"DOI":"10.1167\/iovs.17-23623","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T18:03:14Z","timestamp":1543341794000},"page":"DES151","source":"Crossref","is-referenced-by-count":104,"title":["Secreted Mucins on the Ocular Surface"],"prefix":"10.1167","volume":"59","author":[{"given":"Yuichi","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Toho University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-14-DES151-b01","doi-asserted-by":"crossref","unstructured":"Moniaux N, Escande F, Porchert N, et al. Structural organization and classification of the human mucin genes. Front Biosci. 2001; 6: D1192\u2013D1206.","DOI":"10.2741\/Moniaux"},{"key":"i1552-5783-59-14-DES151-b02","doi-asserted-by":"crossref","unstructured":"Gipson IK, Hori Y, Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf. 2004; 2: 131\u2013148.","DOI":"10.1016\/S1542-0124(12)70149-0"},{"key":"i1552-5783-59-14-DES151-b03","doi-asserted-by":"crossref","unstructured":"Godl K, Johansson ME, Lidell ME, et al. The N terminus of the MUC2 mucin forms trimers that are held together within a Trypsin-resistant core fragment. J Biol Chem. 2002; 277: 47248\u201347256.","DOI":"10.1074\/jbc.M208483200"},{"key":"i1552-5783-59-14-DES151-b04","doi-asserted-by":"crossref","unstructured":"Guyonnet Duperat V, Audie JP, Debailleul V, et al . Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? Biochem J. 1995; 305: 211\u2013219.","DOI":"10.1042\/bj3050211"},{"key":"i1552-5783-59-14-DES151-b05","doi-asserted-by":"crossref","unstructured":"Dufosse J, Porchet N, Audie JP, et al. Degenerate 87-base-pair tandem repeats create hydrophilic\/hydrophobic alternating domains in human mucin peptides mapped to 11p15. Biochem J. 1993; 293: 329\u2013337.","DOI":"10.1042\/bj2930329"},{"key":"i1552-5783-59-14-DES151-b06","doi-asserted-by":"crossref","unstructured":"Portal C, Gouyer V, Magnien M, et al. In vivo imaging of the Muc5b gel-forming mucin. Sci Rep. 2017; 15: 44591.","DOI":"10.1038\/srep44591"},{"key":"i1552-5783-59-14-DES151-b07","doi-asserted-by":"crossref","unstructured":"Toribara NW, Roberton AM, Ho SB, et al. Human gastric mucin: identification of a unique species by expression cloning. J Biol Chem. 1993; 268: 5879\u20135885.","DOI":"10.1016\/S0021-9258(18)53402-5"},{"key":"i1552-5783-59-14-DES151-b08","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhao YH, Kalaslavadi TB, et al. Genome-wide search and identification of a novel gel-forming mucin MUC19\/Muc19 in glandular tissues. Am J Respir Cell Mol Biol. 2004; 30: 155\u2013165.","DOI":"10.1165\/rcmb.2003-0103OC"},{"key":"i1552-5783-59-14-DES151-b09","doi-asserted-by":"crossref","unstructured":"Bobek LA, Tsai H, Biesbrock AR, et al. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem. 1993; 268: 20563\u201320569.","DOI":"10.1016\/S0021-9258(20)80762-5"},{"key":"i1552-5783-59-14-DES151-b10","doi-asserted-by":"crossref","unstructured":"Lapensee L, Paquette Y, Bleau G. Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil Steril. 1997; 68: 702\u2013708.","DOI":"10.1016\/S0015-0282(97)00317-8"},{"key":"i1552-5783-59-14-DES151-b11","doi-asserted-by":"crossref","unstructured":"Gipson IK, Argueso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol. 2003; 231: 1\u201349.","DOI":"10.1016\/S0074-7696(03)31001-0"},{"key":"i1552-5783-59-14-DES151-b12","unstructured":"Inatomi T, Spurr-Michaud S, Tisdale AS, et al. Expression of secretory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci. 1996; 37: 1684\u20131692."},{"key":"i1552-5783-59-14-DES151-b13","doi-asserted-by":"crossref","unstructured":"Jumblatt MM, McKenzie RW, Steele PS, et al. MUC7 expression in the human lacrimal gland and conjunctiva. Cornea. 2003; 22: 41\u201345.","DOI":"10.1097\/00003226-200301000-00010"},{"key":"i1552-5783-59-14-DES151-b14","unstructured":"McKenzie RW, Jumblatt JE, Jumblatt MM. Quantification of MUC2 and MUC5AC transcripts in human conjunctiva. Invest Ophthalmol Vis Sci. 2000; 41: 703\u2013708."},{"key":"i1552-5783-59-14-DES151-b15","doi-asserted-by":"crossref","unstructured":"Yu DF, Chen Y, Han JM, et al. MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjogren syndrome patients. Exp Eye Res. 2008; 86: 403\u2013411.","DOI":"10.1016\/j.exer.2007.11.013"},{"key":"i1552-5783-59-14-DES151-b16","unstructured":"Inatomi T, Spurr-Michaud S, Tisdale AS, Gipson IK. Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci. 1995; 36: 1818\u20131827."},{"key":"i1552-5783-59-14-DES151-b17","unstructured":"Pflugfelder SC, Liu Z, Monroy D, et al. Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest Ophthalmol Vis Sci. 2000; 125: 323\u2013336."},{"key":"i1552-5783-59-14-DES151-b18","doi-asserted-by":"crossref","unstructured":"Argueso P, Spurr-Michaud S, Russo CL, et al. MUC16 mucin is expressed by the human ocular surface epithelia and carries H185 carbohydrate epitope. Invest Ophthalmol Vis Sci. 2003; 44: 2487\u20132495.","DOI":"10.1167\/iovs.02-0862"},{"key":"i1552-5783-59-14-DES151-b19","doi-asserted-by":"crossref","unstructured":"Woodward AM, Argueso P. Expression analysis of the transmembrane mucin MUC20 in human corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci. 2014; 55: 6132\u20136138.","DOI":"10.1167\/iovs.14-15269"},{"key":"i1552-5783-59-14-DES151-b20","doi-asserted-by":"crossref","unstructured":"Gipson IK. Goblet cells of the conjunctiva: A review of recent findings. Prog Retin Eye Res. 2016; 54: 49\u201363.","DOI":"10.1016\/j.preteyeres.2016.04.005"},{"key":"i1552-5783-59-14-DES151-b21","unstructured":"Kessing SV. Mucous gland system of the conjunctiva. A quantitative normal anatomical study. Acta Ophthalmol (Copenh). 1968; 95 (suppl): 1\u2013133."},{"key":"i1552-5783-59-14-DES151-b22","doi-asserted-by":"crossref","unstructured":"Knop E, Knop N, Zhivov A, et al. The lid wiper and muco-cutaneous junction anatomy of the human eyelid margins: an in vivo confocal and histological study. J Anat. 2011; 218: 449\u2013461.","DOI":"10.1111\/j.1469-7580.2011.01355.x"},{"key":"i1552-5783-59-14-DES151-b23","doi-asserted-by":"crossref","unstructured":"Knop N, Korb DR, Blackie CA, et al. The lid wiper contains goblet cells and goblet crypts for ocular surface lubrication during the blink. Cornea. 2012; 31: 668\u2013679.","DOI":"10.1097\/ICO.0b013e31823f8d8c"},{"key":"i1552-5783-59-14-DES151-b24","doi-asserted-by":"crossref","unstructured":"Kase S, Shinohara T, Kase M. Effect of topical rebamipide on goblet cells in the lid wiper of human conjunctiva. Exp Eye Res. 2017; 13: 3516\u20133522.","DOI":"10.3892\/etm.2017.4390"},{"key":"i1552-5783-59-14-DES151-b25","unstructured":"Diebold Y, Rios JD, Hodges RR, et al. Presence of nerves and their receptors in mouse and human conjunctival goblet cells. Invest Ophthalmol Vis Sci. 2001; 42: 2270\u20132282."},{"key":"i1552-5783-59-14-DES151-b26","unstructured":"Rios JD, Zoukhri D, Rawe IM, et al. Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. Invest Ophthalmol Vis Sci. 1999; 40: 1102\u20131111."},{"key":"i1552-5783-59-14-DES151-b27","doi-asserted-by":"crossref","unstructured":"Kanno H, Horikawa Y, Hodges RR, et al. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. Am J Physiol Cell Physiol. 2003; 284: C988\u2013C998.","DOI":"10.1152\/ajpcell.00582.2001"},{"key":"i1552-5783-59-14-DES151-b28","doi-asserted-by":"crossref","unstructured":"Hodges RR, Bair JA, Carozza RB, et al. Signaling pathways used by EGF to stimulate conjunctival goblet cell secretion. Exp Eye Res. 2012; 103: 99\u2013113.","DOI":"10.1016\/j.exer.2012.08.010"},{"key":"i1552-5783-59-14-DES151-b29","doi-asserted-by":"crossref","unstructured":"Rios JD, Shatos MA, Urashima H, et al. Effect of OPC-12759 on EGF receptor activation, p44\/p42 MAPK activity, and secretion in conjunctival goblet cells. Exp Eye Res. 2008; 86: 629\u2013636.","DOI":"10.1016\/j.exer.2008.01.007"},{"key":"i1552-5783-59-14-DES151-b30","doi-asserted-by":"crossref","unstructured":"Floyd AM, Zhou Xu, Evans C, et al. Mucin deficiency causes functional and structural changes of the ocular surface. PLoS One. 2012; 12: e50704.","DOI":"10.1371\/journal.pone.0050704"},{"key":"i1552-5783-59-14-DES151-b31","doi-asserted-by":"crossref","unstructured":"Marko CK, Tisdale AS, Spurr-Michaud S, et al. The ocular surface phenotype of Muc5ac and Muc5b null mice. Invest Ophthalmol Vis Sci. 2014; 55: 291\u2013300.","DOI":"10.1167\/iovs.13-13194"},{"key":"i1552-5783-59-14-DES151-b32","doi-asserted-by":"crossref","unstructured":"Marko CK, Menon BB, Chen G, et al. Spdef null mice lack conjunctival goblet cells and provide a model. Am J Pathol. 2013; 183: 35\u201348.","DOI":"10.1016\/j.ajpath.2013.03.017"},{"key":"i1552-5783-59-14-DES151-b33","unstructured":"Argueso P, Balaram M, Spurr-Michaud S, et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci. 2002; 43: 1004\u20131011."},{"key":"i1552-5783-59-14-DES151-b34","doi-asserted-by":"crossref","unstructured":"Shimazaki-Den S, Dogru M, Higa K, et al. Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea. 2013; 32: 1211\u20131218.","DOI":"10.1097\/ICO.0b013e318295a2a5"},{"key":"i1552-5783-59-14-DES151-b35","doi-asserted-by":"crossref","unstructured":"Zhang X, De Paiva CS, Su Z, et al. Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye. Exp Eye Res. 2014; 118: 117\u2013124.","DOI":"10.1016\/j.exer.2013.11.011"},{"key":"i1552-5783-59-14-DES151-b36","doi-asserted-by":"crossref","unstructured":"Henriksson JT, Coursey TG, Corry DB, et al. IL-13 stimulates proliferation and expression of mucin and immunomodulatory genes in cultured conjunctival goblet cells. Invest Ophthalmol Vis Sci. 2015; 56: 4186\u20134197.","DOI":"10.1167\/iovs.14-15496"},{"key":"i1552-5783-59-14-DES151-b37","doi-asserted-by":"crossref","unstructured":"Pflugfelder SC, De Paiva CS, Moore QL, et al. Aqueous tear deficiency increases conjunctival interferon-gamma (IFN-gamma) expression and goblet cell loss. Invest Ophthalmol Vis Sci. 2015; 56: 7545\u20137550.","DOI":"10.1167\/iovs.15-17627"},{"key":"i1552-5783-59-14-DES151-b38","unstructured":"Kunert KS, Keane-Myers AM, Spurr-Michaud S, et al. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci. 2001; 42: 2483\u20132489."},{"key":"i1552-5783-59-14-DES151-b39","doi-asserted-by":"crossref","unstructured":"Dogru M, Matsumoto Y, Okada N, et al. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy. 2008; 63: 1324\u20131334.","DOI":"10.1111\/j.1398-9995.2008.01781.x"},{"key":"i1552-5783-59-14-DES151-b40","doi-asserted-by":"crossref","unstructured":"International Dry Eye Workshop. Management and therapy of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007; 5: 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"i1552-5783-59-14-DES151-b41","doi-asserted-by":"crossref","unstructured":"Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017; 15: 575\u2013628.","DOI":"10.1016\/j.jtos.2017.05.006"},{"key":"i1552-5783-59-14-DES151-b42","doi-asserted-by":"crossref","unstructured":"Uchino M, Yokoi N, Uchino Y, et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka Study. Am J Ophthalmol. 2013; 156: 759\u2013766.","DOI":"10.1016\/j.ajo.2013.05.040"},{"key":"i1552-5783-59-14-DES151-b43","doi-asserted-by":"crossref","unstructured":"Uchino Y, Uchino M, Yokoi N, et al. Alteration of tear mucin 5AC in office workers using visual display terminals: the Osaka Study. JAMA Ophthalmol. 2014; 132: 985\u2013992.","DOI":"10.1001\/jamaophthalmol.2014.1008"},{"key":"i1552-5783-59-14-DES151-b44","doi-asserted-by":"crossref","unstructured":"Uchino Y, Uchino M, Yokoi N, et al. Impact of cigarette smoking on tear function and correlation between conjunctival goblet cells and tear MUC5AC concentration in office workers. Sci Rep. 2016; 6: 27699.","DOI":"10.1038\/srep27699"},{"key":"i1552-5783-59-14-DES151-b45","doi-asserted-by":"crossref","unstructured":"Cowlen MS, Zhang VZ, Warnock L, Moyer CF, Peterson WM, Yerxa BR. Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp Eye Res. 2003; 77: 77\u201384.","DOI":"10.1016\/S0014-4835(03)00068-X"},{"key":"i1552-5783-59-14-DES151-b46","doi-asserted-by":"crossref","unstructured":"Jumblatt JE, Jumblatt MM. Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. Exp Eye Res. 1998; 67: 341\u2013346.","DOI":"10.1006\/exer.1998.0520"},{"key":"i1552-5783-59-14-DES151-b47","doi-asserted-by":"crossref","unstructured":"Nakamura M, Imanaka T, Sakamoto A. Diquafosol ophthalmic solution for dry eye treatment. Adv Ther. 2012; 29: 579\u2013589.","DOI":"10.1007\/s12325-012-0033-9"},{"key":"i1552-5783-59-14-DES151-b48","unstructured":"Takaoka-Shichijo Y, Murakami T, Nakamura M. Stimulatory effect of diquafosol tetrasodium on tear fluid secretion in normal rabbits [in Japanese]. Atarashii Ganka. 2011; 28: 1029\u20131033."},{"key":"i1552-5783-59-14-DES151-b49","unstructured":"Fujihara T, Murakami T, Fujita H, et al. Improvement of corneal barrier function by the P2Y2 agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci. 2001; 42: 96\u2013100."},{"key":"i1552-5783-59-14-DES151-b50","doi-asserted-by":"crossref","unstructured":"Hori Y, Kageyama T, Sakamoto A, et al. Comparison of short-term effects of diquafosol and rebamipide on mucin 5AC level on the rabbit ocular surface. J Ocul Pharmacol Ther. 2017; 33: 493\u2013497.","DOI":"10.1089\/jop.2016.0092"},{"key":"i1552-5783-59-14-DES151-b51","unstructured":"Takaoka-Shichijo Y, Nakamura M. Stimulatory effect of diquafosol tetrasodium on the expression of membrane-binding mucin genes in cultured human corneal epithelial cells [in Japanese]. J Eye. 2011; 28: 425\u2013429."},{"key":"i1552-5783-59-14-DES151-b52","doi-asserted-by":"crossref","unstructured":"Kamiya K, Nakanishi M, Ishii R, et al. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective randomized, multicenter study. Eye (Lond). 2012; 26: 1363\u20131368.","DOI":"10.1038\/eye.2012.166"},{"key":"i1552-5783-59-14-DES151-b53","doi-asserted-by":"crossref","unstructured":"Koh S, Ikeda C, Takai Y, et al. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye. Jpn J Ophthalmol. 2013; 57: 440\u2013446.","DOI":"10.1007\/s10384-013-0251-y"},{"key":"i1552-5783-59-14-DES151-b54","doi-asserted-by":"crossref","unstructured":"Shimazaki-Den S, Iseda H, Dogru M, et al. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Cornea. 2013; 32: 1120\u20131125.","DOI":"10.1097\/ICO.0b013e3182930b1d"},{"key":"i1552-5783-59-14-DES151-b55","doi-asserted-by":"crossref","unstructured":"Kaido M, Uchino M, Kojima T, et al. Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye. J Ocul Pharmacol Ther. 2013; 29: 595\u2013603.","DOI":"10.1089\/jop.2012.0246"},{"key":"i1552-5783-59-14-DES151-b56","doi-asserted-by":"crossref","unstructured":"Kobashi H, Kamiya K, Igarashi A, et al. Intraocular scattering after instillation of diquafosol ophthalmic solution. Optom Vis Sci. 2015; 92: e303\u2013e309.","DOI":"10.1097\/OPX.0000000000000490"},{"key":"i1552-5783-59-14-DES151-b57","doi-asserted-by":"crossref","unstructured":"Toda I, Ide T, Fukumoto T, et al. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis. Am J Ophthalmol. 2014; 157: 616\u2013622.","DOI":"10.1016\/j.ajo.2013.11.017"},{"key":"i1552-5783-59-14-DES151-b58","doi-asserted-by":"crossref","unstructured":"Mori Y, Nejima R, Masuda A, et al. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis. Cornea. 2014; 33: 659\u2013662.","DOI":"10.1097\/ICO.0000000000000136"},{"key":"i1552-5783-59-14-DES151-b59","doi-asserted-by":"crossref","unstructured":"Arita R, Suehiro J, Haraguchi T, et al. Topical diquafosol for patients with obstructive Meibomian gland dysfunction. Br J Ophthalmol. 2013; 97: 725\u2013729.","DOI":"10.1136\/bjophthalmol-2012-302668"},{"key":"i1552-5783-59-14-DES151-b60","doi-asserted-by":"crossref","unstructured":"Arakawa T, Higuchi K, Fujiwara Y, et al. 15th Anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Digest Dis Sci. 2005; 50 (suppl 1): S3\u2013S11.","DOI":"10.1007\/s10620-005-2800-9"},{"key":"i1552-5783-59-14-DES151-b61","doi-asserted-by":"crossref","unstructured":"Urashima H, Takeji Y, Okamoto T, Fujisawa S, Shinohara H. Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits. J Ocul Pharmacol Ther. 2012; 28: 264\u2013270.","DOI":"10.1089\/jop.2011.0147"},{"key":"i1552-5783-59-14-DES151-b62","doi-asserted-by":"crossref","unstructured":"Urashima H, Okamoto T, Takeji Y, et al. Rebamipide increases the amount of mucin-like substances on the conjunctival and cornea in the N-acetylcysteine treated in vivo model. Cornea. 2004; 23: 613\u2013619.","DOI":"10.1097\/01.ico.0000126436.25751.fb"},{"key":"i1552-5783-59-14-DES151-b63","doi-asserted-by":"crossref","unstructured":"Ohguchi T, Kojima T, Ibrahim OM, et al. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice. Invest Ophthalmol Vis Sci. 2013; 54: 7793\u20137802.","DOI":"10.1167\/iovs.13-13128"},{"key":"i1552-5783-59-14-DES151-b64","doi-asserted-by":"crossref","unstructured":"Kase S, Shinohara T, Kase M. Effect of topical rebamipide on human conjunctival goblet cells. JAMA Ophthalmol. 2014; 132: 1021\u20131022.","DOI":"10.1001\/jamaophthalmol.2014.431"},{"key":"i1552-5783-59-14-DES151-b65","doi-asserted-by":"crossref","unstructured":"Itoh S, Itoh K, Shinohara H. Regulation of human corneal epithelial mucins by rebamipide. Curr Eye Res. 2014; 39: 133\u2013141.","DOI":"10.3109\/02713683.2013.834939"},{"key":"i1552-5783-59-14-DES151-b66","doi-asserted-by":"crossref","unstructured":"Uchino Y, Woodward AM, Argueso P. Differential effect of rebamipide on transmembrane mucin biosynthesis in stratified ocular surface epithelial cells. Exp Eye Res. 2016; 153: 1\u20137.","DOI":"10.1016\/j.exer.2016.10.007"},{"key":"i1552-5783-59-14-DES151-b67","doi-asserted-by":"crossref","unstructured":"Tanaka H, Fukuda K, Ishida W. Rebamipide increases barrier function and attenuates TNF alpha-induced barrier function and cytokine expression in human corneal cells. Br J Ophthalmol. 2013; 97: 912\u2013916.","DOI":"10.1136\/bjophthalmol-2012-302868"},{"key":"i1552-5783-59-14-DES151-b68","doi-asserted-by":"crossref","unstructured":"Kimura K, Morita Y, Orita T, et al. Protection of human corneal epithelial cells from TNF-alpha-induced disruption of barrier function by rebamipide. Invest Ophthalmol Vis Sci. 2013; 54: 2572\u20132760.","DOI":"10.1167\/iovs.12-11294"},{"key":"i1552-5783-59-14-DES151-b69","doi-asserted-by":"crossref","unstructured":"Kato K, Takashima Y, Matsunaga K, et al. Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy. Sci Rep. 2016; 6: 19516.","DOI":"10.1038\/srep19516"},{"key":"i1552-5783-59-14-DES151-b70","doi-asserted-by":"crossref","unstructured":"Kato K, Miyake K, Kondo N, et al. Conjunctival goblet cell density following cataract surgery with diclofenac versus diclofenac and rebamipide: a randomized trial. Am J Ophthalmol. 2017; 181: 26\u201336.","DOI":"10.1016\/j.ajo.2017.06.016"},{"key":"i1552-5783-59-14-DES151-b71","unstructured":"Hori Y, Maeno T. Effects of diquafosol ophthalmic solutions and rebamipide ophthalmic suspension on tear fluid volume in normal rabbit [in Japanese]. Atarashii Ganka. 2013; 30: 1007\u20131010."}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2717226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:50Z","timestamp":1791927050000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.17-23623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":71,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.17-23623","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,27]]}}}